1. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study
- Author
-
Jong Hyun Tae, Ji Sung Shim, Sung Goo Yoon, Jae Young Park, Jae Hyun Bae, Seok Ho Kang, Tae Il Noh, Hoon Choi, and Hong Seok Park
- Subjects
Male ,Reoperation ,medicine.medical_specialty ,Neoplasm, Residual ,Urological Oncology ,medicine.medical_treatment ,Urinary bladder neoplasms ,Tumor resection ,Neoplasm invasiveness ,Urology ,Kaplan-Meier Estimate ,Cystectomy ,Resection ,Recurrence ,Medicine ,Humans ,In patient ,Clinical significance ,Prospective Studies ,Prospective cohort study ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Bladder cancer ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,Prognosis ,Surgery ,Treatment Outcome ,Original Article ,Female ,Neoplasm Grading ,business - Abstract
Purpose This study was designed to estimate the value of a second transurethral resection of bladder tumor (TURBT) procedure in patients with initially diagnosed T1 high-grade bladder cancer. Materials and Methods Between August 2009 and January 2013, a total of 29 patients with T1 high-grade bladder cancer prospectively underwent a second TURBT procedure. Evaluation included the presence of previously undetected residual tumor, changes to histopathological staging or grading, and tumor location. Recurrence-free and progression-free survival curves were generated to compare the prognosis between the groups with and without residual lesions by use of the Kaplan-Meier method. Results Of 29 patients, 22 patients (75.9%) had residual disease after the second TURBT. Staging was as follows: no tumor, 7 (24.1%); Ta, 5 (17.2%); T1, 6 (20.7%); Tis, 6 (20.7%); Ta+Tis, 1 (3.4%); T1+Tis, 1 (3.4%); and ≥T2, 3 (10.3%). The muscle layer was included in the surgical specimen after the initial TURBT in 24 patients (82.7%). In three patients whose cancer was upstaged to pT2 after the second TURBT, the initial surgical specimen contained the muscle layer. In the group with residual lesions, the 3-year recurrence-free survival and 3-year progression-free survival rates were 50% and 66.9%, respectively, whereas these rates were 68.6% and 68.6%, respectively, in the group without residual lesions. This difference was not statistically significant. Conclusions Initial TURBT does not seem to be enough to control T1 high-grade bladder cancer. Therefore, a routine second TURBT procedure should be recommended in patients with T1 high-grade bladder cancer to accomplish adequate tumor resection and to identify patients who may need to undergo prompt cystectomy.
- Published
- 2015